Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis

S. Van daele, P. Schelstraete, F. Haerynck, F. De Baets (Ghent, Belgium)

Source: Annual Congress 2010 - New aspects of cystic fibrosis
Session: New aspects of cystic fibrosis
Session type: Thematic Poster Session
Number: 4797
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Van daele, P. Schelstraete, F. Haerynck, F. De Baets (Ghent, Belgium). Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis. Eur Respir J 2010; 36: Suppl. 54, 4797

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients
Source: Eur Respir J 2001 Jan 01;19(4):743-755
Year: 2002



Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015



Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis
Source: Eur Respir J 2012; 40: 271-273
Year: 2012


Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011


Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003

Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA).
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Comparison of clinical characteristics of invasive tracheobronchial aspergillosis with or without invasive pulmonary aspergillosis
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 432s
Year: 2001

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011



Surgical treatment of invasive aspergillosis
Source: Eur Respir Monogr 2013; 61: 58-65
Year: 2013


To identify cases of invasive pulmonary aspergillosis in patients of COPD with sputum positive for aspergillus by applying existing criteria
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010

VATS-resection and lobectomy for invasive pulmonary aspergillosis in severely immunocompromised patients with hematologic diseases
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010

Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG)
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010


Mini-bronchoalveolar lavage for diagnosing COVID-19 associated invasive pulmonary aspergillosis.
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021

Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008



Surgery treatment of pulmonary aspergillosis
Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology
Year: 2007